中国药物警戒 ›› 2010, Vol. 7 ›› Issue (4): 224-225.

• 管理研究 • 上一篇    下一篇

从通报头孢拉定不良反应看药品风险管理

王春婷   

  1. 国家食品药品监督管理局药品评价中心,北京 100045
  • 收稿日期:2016-02-19 修回日期:2016-02-19 出版日期:2010-04-08 发布日期:2016-02-19
  • 作者简介:王春婷,女,副主任药师,药品不良反应监测和药物警戒。

Analysis of Drug Risk Management Through Issuing the Information Bulletin about Cefradin

WANG Chun-ting   

  1. Center for Drug Reevaluation, SFDA, Beijing 100045, China
  • Received:2016-02-19 Revised:2016-02-19 Online:2010-04-08 Published:2016-02-19

摘要: 通过介绍头孢拉定致血尿的不良反应情况,回顾我国《药品不良反应信息通报》对该药的通报情况及相应的风险管理措施,系统分析药品风险管理各环节的作用及产生的影响,以加深对药品风险管理的理解与认识,促进我国药品风险管理的开展与实现。

关键词: 头孢拉定, 血尿, 药品不良反应, 药品风险管理

Abstract: The condition of hematuria induced by Cefradin have been introduced, the information bulletin of adverse drug reaction about Cefradin and relevant risk management measures have been reviewed in this article. On this basis, the role and effect of all processes of drug risk management have been analyzed to deepen understanding of drugs risk management and promote this work in China.

Key words: Cefradin, hematuria, adverse drug reaction, drug risk management

中图分类号: